CFS/ME – fra hysteri til biomedisinsk sykdom
Tidsskr Nor Laegeforen, 146
DOI 10.4045/tidsskr.25.0729, PubMed 41556825
Plain Language Summary on Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study
Eur J Haematol (in press)
DOI 10.1111/ejh.70078, PubMed 41531337
Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study
Eur J Haematol (in press)
DOI 10.1111/ejh.70059, PubMed 41486550